Study Stopped
Administratively closed because no Continuing Review submitted
Mathematical Modeling to Determine Basic Muscle Properties in the Failing Heart
1 other identifier
observational
37
1 country
1
Brief Summary
According to the most recent information released by the American Heart Association, heart failure affects 5.8 million Americans and over 23 million people worldwide. In particular, diastolic heart failure (DHF) has emerged in approximately half of those suffering from heart disease and has become a major public health problem for many reasons, including the complexity of the disease, lack of effective drugs/therapies, requirement of invasive tests to diagnose and monitor DHF, and the absence of a suitable scientific model to study the disease. Scientists and physicians alike still do not fully understand what happens to the muscles in the heart (myocardium) patients who present with diastolic dysfunction or DHF. Therefore, the medical field is in need of an accurate model that can evaluate how diastolic dysfunction leads to heart failure and what happens at a cellular level as this disease emerges and progresses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 25, 2013
CompletedFirst Posted
Study publicly available on registry
January 29, 2013
CompletedStudy Start
First participant enrolled
September 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 3, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 3, 2022
CompletedAugust 29, 2023
August 1, 2023
8.4 years
January 25, 2013
August 26, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The longitudinal assessment of myocardial properties in subjects with Diastolic Heart Failure.
Our mathematical model of the heart integrates the cellular mechanisms of sarcomere dynamics with the overall functional properties of the ventricle. Utilizing specific measurements captured by echo, estimates of basic muscle properties in subjects suffering from DHF will be compared to observed properties. Echo measurements will be taken at baseline and 2 weeks, 4 months, 8 months, 1 year, and 2 years following therapy.
2 years
Secondary Outcomes (2)
Correlation of observed muscle properties to clinical outcomes/status.
2 years
Validation of the developing mathematical model using the data points collected from echocardiographic procedures
1 baseline echocardiograph
Study Arms (2)
Healthy Control
Healthy controls with no history of heart disease or heart failure. Subjects will undergo a medical history review and 1 echocardiograph procedure.
>Grade 2 Diastolic Dysfunction
Diastolic Heart Failure, \> Grade II (NYHA functional class) and/or \> Grade II Diastolic Dysfunction as evaluated by echocardiography
Eligibility Criteria
Normal controls will be recruited from the Omaha community. Subjects with Diastolic Heart Dysfunction and/or Failure will be selected from The University of Nebraska Medical Center Heart Clinic or from The Nebraska Medical Center Hospital.
You may qualify if:
- Subjects must be 19 years of age or older
- Control subjects must have no prior history or current signs of heart disease.
- Subjects with heart failure must meet one or more of the following criteria:
- Documented Diastolic Heart Failure, Grade II or greater (via NYHA functional class)
- Grade II or greater Diastolic Dysfunction by echocardiographic evaluation
You may not qualify if:
- Subjects under the age of 19 or unable to give consent will be excluded from this study.
- Greater than mild valvular disease
- Prior valve repair/replacement
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
Related Publications (3)
Kass DA, Bronzwaer JG, Paulus WJ. What mechanisms underlie diastolic dysfunction in heart failure? Circ Res. 2004 Jun 25;94(12):1533-42. doi: 10.1161/01.RES.0000129254.25507.d6.
PMID: 15217918BACKGROUNDPaulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, Borbely A, Edes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007 Oct;28(20):2539-50. doi: 10.1093/eurheartj/ehm037. Epub 2007 Apr 11.
PMID: 17428822BACKGROUNDMoulton MJ, Creswell LL, Actis RL, Myers KW, Vannier MW, Szabo BA, Pasque MK. An inverse approach to determining myocardial material properties. J Biomech. 1995 Aug;28(8):935-48. doi: 10.1016/0021-9290(94)00144-s.
PMID: 7673261BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Moulton J Moulton, MD
University of Nebraska
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 25, 2013
First Posted
January 29, 2013
Study Start
September 1, 2013
Primary Completion
February 3, 2022
Study Completion
February 3, 2022
Last Updated
August 29, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share